首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1271240

微針流感疫苗市場，按產品類型、疫苗類型、流感類型（A型、B型流感）、地區 - 規模、份額、前景、機會分析2023-2030

Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Flu Type (Influenza A, Influenza B), By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年03月28日 | 出版商:

Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

使用透皮貼劑通過皮膚輸送藥物始終能有效對抗病毒感染和流感。經皮藥物遞送主要通過被動藥物擴散有效地進行，然後已經進行了通過各種作用機制（例如離子電滲療法和超聲導入）的經皮遞送系統的藥物開發。此外，製藥公司已專注於開發微針疫苗，因為它們對於非常大的離子和親水性藥物分子的透皮遞送非常有用。在微針中，有一種藥物以穿透皮膚的針狀進入體內。微針有多種尺寸、形狀和功能，所有這些都用於替代其他輸送方法，例如傳統的皮下注射針頭和其他注射裝置。

微針貼片旨在將藥物精確輸送到富含免疫細胞的皮內空間，提供一種非侵入性和自我應用的疫苗接種方法，為疫苗接種提供了一種可行的替代方案。無需皮下注射針頭和訓練有素的醫療人員人員。

市場動態

為了擴大產品組合，市場上的主要參與者越來越多地採用產品發布等有機增長策略，預計這將在預測期內推動市場增長。例如，2021 年 6 月，主要美容和醫療製造商 Eclipse Foundation 宣布推出新產品 MicroPen EVO，這是一種醫療微針設備。

市場參與者增加微針流感疫苗的臨床試驗以擴大其產品組合，預計將在預測期內推動市場增長。例如，2021 年 7 月，處於臨床階段的生物製藥公司 Micron Biomedical, Inc. 宣布已開始一項基於微針的麻疹風疹疫苗的兒科臨床試驗。

這項研究的主要特點

本報告對全球微針流感疫苗市場進行了深入分析，並展示了以 2022 年為基準年的預測期 (2023-2030) 的市場規模和復合年增長率。
它揭示了各個細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
它根據以下參數介紹了全球微針流感疫苗市場的主要參與者：公司亮點、產品組合、主要亮點、財務業績和戰略。
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
《全球微針流感疫苗市場報告》面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球微針流感疫苗市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫

第二章市場展望

報告概述
- 市場定義和範圍
執行摘要
- 按產品類型劃分的市場概況
- 市場概況，按疫苗類型
- 市場概況，按流感類型
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 市場吸引力分析
- 市場機會
產品公告
合併、收購、聯合研究
監管準則和合規性
主要發展狀況
害蟲分析
疫苗類型情況
對 PORTER 的分析
價格分析 (2021)

第 4 章全球微針流感疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響

經濟影響
COVID-19 的流行病學特徵
對供需的影響

第 5 章按產品類型劃分的全球微針流感疫苗市場，2017-2030

實心微針
空心微針
塗層微針
可溶性微針

第 6 章全球微針流感疫苗市場，按疫苗類型分列，2017-2030

三價流感疫苗
四價流感疫苗

第 7 章全球微針流感疫苗市場，按流感類型分列，2017-2030

甲型流感
甲型H1N1
H3N2 型
乙型流感

第 8 章全球微針流感疫苗市場，按地區劃分，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第9章競爭格局

疫苗公司：
- Vaccine Companies：
  - Sanofi
  - GC Pharma
- Microneedle Companies：
  - Harro Hofliger
  - CosMED Pharmaceutical Co.Ltd.
  - Micron Biomedical, Inc.
  - LTS Lohmann Therapie-Systeme AG
  - Micralyne, Inc.
  - Sorrento Therapeutics, Inc.
  - TSRL, Inc.
  - QUADMEDICINE
  - Raphas Co., Ltd.
  - Cutanos GmbH
  - 3M
  - NanoPass
  - Corium, Inc.
  - BD
  - FluGen, Inc.
  - MICRODERMICS INC
第 10 章
- 調查方法
- 關於出版商

簡介目錄

Product Code: CMI2286

Drug delivery through the skin using transdermal patches has always been effective against viral infections and influenza. Transdermal drug delivery is primarily efficient through passive drug diffusion followed by drug development of transdermal delivery systems through various mechanisms of action such as iontophoresis and sonophoresis. Moreover, pharmaceutical companies have focused on the development of microneedle vaccines because of their great utility for transdermal delivery of very large ionic and hydrophilic drug molecules. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus.

Microneedle patches are designed to precisely deliver drugs into the intradermal space, rich in immune cells, and provide a noninvasive and self-applicable vaccination approach, eliminating the need for hypodermic needles and trained medical personnel for vaccine administration.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launches by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2021, Eclipse Foundation, a leading aesthetic and medical manufacturer, announced the launch of its new product MicroPen EVO, which is a medical-grade micro-needling device.

The increasing clinical trials of the microneedle flu vaccine by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in July 2021, Micron Biomedical, Inc., a clinical stage biopharmaceutical company announced that it has begun trialing a microneedle-based measles-rubella vaccine in children.

Key features of the study:

This report provides in-depth analysis of the global microneedle flu vaccine market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global microneedle flu vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Sanofi, GC Pharma, Harro Hofliger, CosMED Pharmaceutical Co.Ltd., Micron Biomedical, Inc., LTS Lohmann Therapie-Systeme AG, Micralyne, Inc., Sorrento Therapeutics, Inc., TSRL, Inc., QUADMEDICINE, Raphas Co., Ltd., Cutanos GmbH, 3M, NanoPass, Corium, Inc., BD, FluGen, Inc., MICRODERMICS INC
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global microneedle flu vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microneedle flu vaccine market

Detailed Segmentation:

Global Microneedle Flu Vaccine Market, By Product Type:
- Solid Microneedles
- Hollow Microneedles
- Coated Microneedles
- Dissolving Microneedles
Global Microneedle Flu Vaccine Market, By Vaccine :
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
Global Microneedle Flu Vaccine Market By Flu Type:
- Influenza A
  - H1N1
  - H3N2
- Influenza B
Global Microneedle Flu Vaccine Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Sanofi*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GC Pharma
- Harro Hofliger
- CosMED Pharmaceutical Co.Ltd.
- Micron Biomedical, Inc.
- LTS Lohmann Therapie-Systeme AG
- Micralyne, Inc.
- Sorrento Therapeutics, Inc.
- TSRL, Inc.
- QUADMEDICINE
- Raphas Co., Ltd.
- Cutanos GmbH
- 3M
- NanoPass
- Corium, Inc.
- BD
- FluGen, Inc.
- MICRODERMICS INC

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Flu Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Vaccine Type Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Microneedle Flu Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Microneedle Flu Vaccine Market, By Product Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Solid Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hollow Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Coated Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Dissolving Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Microneedle Flu Vaccine Market, By Vaccine Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Trivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Quadrivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Microneedle Flu Vaccine Market, By Flu Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Influenza A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
H1N1
H3N2
Influenza B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Microneedle Flu Vaccine Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa